Katamesh et al. found that in 18% of MDS cases that progressed to AML, an increased co-mutational burden was present, which drives progression, suggesting that STAG2 mutations promote leukemic transformation by inducing genetic instability and facilitating the acquisition of additional alterations [65]. This evidence concerns the gene STAG2 and myelodysplastic syndrome.